Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer

被引：0
|
作者：
Masafumi Ikeda
Hideaki Takahashi
Shunsuke Kondo
Michael Mauritius Fabio Lahn
Ken Ogasawara
Karim A. Benhadji
Hisaki Fujii
Hideki Ueno
机构：
[1] National Cancer Center Hospital East,
[2] National Cancer Center Hospital,undefined
[3] Johns Hopkins Bloomberg School of Public Health,undefined
[4] Eli Lilly and Company,undefined
[5] Eli Lilly Japan K.K.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 79卷
关键词：
Galunisertib; Gemcitabine; Japanese; Pancreatic cancer; Pharmacokinetics; Phase 1b; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1169 / 1177
页数：8
相关论文
共 50 条
  • [1] Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer
    Ikeda, Masafumi
    Takahashi, Hideaki
    Kondo, Shunsuke
    Lahn, Michael Mauritius Fabio
    Ogasawara, Ken
    Benhadji, Karim A.
    Fujii, Hisaki
    Ueno, Hideki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1169 - 1177
  • [2] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [3] Phase 1b study of nimotuzumab in combination with concurrent chemoradiotherapy in Japanese patients with locally advanced esophageal cancer
    Ura, T.
    Kato, K.
    Koizumi, W.
    Iwasa, S.
    Katada, C.
    Azuma, M.
    Ishikura, S.
    Nakao, Y.
    Onuma, H.
    Muro, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
    Yaman Suleiman
    Amit Mahipal
    David Shibata
    Erin M. Siegel
    Helen Jump
    William J. Fulp
    Gregory M. Springett
    Richard Kim
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 481 - 487
  • [5] A phase 1b/2 trial of SHR-1701 in combination with gemcitabine and nab-paclitaxel in patients with untreated locally advanced or metastatic pancreatic cancer.
    Zhou, Jun
    Yu, Xianjun
    Li, Zhihua
    Zhou, Yuhong
    Li, Jialin
    Xue, Ran
    Xia, Ye
    Han, Hongxia
    Wu, Yiwen
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16264 - E16264
  • [6] Phase I study of combination of pasireotide LAR plus gemcitabine in locally advanced or metastatic pancreatic cancer
    Suleiman, Yaman
    Mahipal, Amit
    Shibata, David
    Siegel, Erin M.
    Jump, Helen
    Fulp, William J.
    Springett, Gregory M.
    Kim, Richard
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 481 - 487
  • [7] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [8] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [9] Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
    Harding, James J.
    Do, Richard K.
    Yaqubie, Amin
    Cleverly, Ann
    Zhao, Yumin
    Gueorguieva, Ivelina
    Lahn, Michael
    Benhadji, Karim A.
    Kelley, Robin K.
    Abou-Alfa, Ghassan K.
    CANCER MEDICINE, 2021, 10 (09): : 3059 - 3067
  • [10] A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinoma
    Jo, J.
    Lee, H.
    Park, S.
    Chung, D.
    Cho, S.
    Cha, H.
    Cho, J.
    Song, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S211 - S211
12345